USA — Fresh off its remarkable success in the field of biomedicine with its COVID-19 vaccine, Moderna is charting an audacious path forward. The company has unveiled a bold roadmap…
Read MoreTag: Moderna
Moderna expands mRNA-based cancer research with US$1.8 billion deal with Immatics
USA — Moderna, the Massachusetts-based pioneer in mRNA technology, has entered into a substantial agreement worth up to US$1.8 billion with Immatics, a specialist in T-cell receptor (TCR) therapies. This…
Read MoreModerna unveils ambitious strategy bridging cancer targets through mRNA vaccine and solid tumor CAR-T combination
USA — In an unprecedented collaboration that holds promise for the future of cancer treatment, Moderna and China’s CARsgen Therapeutics have announced their partnership to combine cutting-edge medical technologies. The…
Read MoreModerna looks to rise beyond a 94% COVID-19 vaccine revenue decline, banking on boosters to transform its path forward
USA — The trajectory of Moderna, once heralded for its COVID-19 vaccine triumph, has encountered a significant pivot as the company grapples with a substantial decline in vaccine sales. Despite…
Read MoreModerna and Merck begin late-stage study on personalized mRNA-based skin cancer vaccine
USA —Moderna and Merck have commenced patient enrollment in a late-stage study to test their personalized mRNA-based skin cancer vaccine in combination with the immunotherapy Keytruda. The vaccine aims to…
Read MoreModerna initiates regulatory submissions for RSV vaccine, aiming to enter multibillion-dollar market
USA — Moderna, a renowned vaccine manufacturer, has announced that it has commenced a rolling submission to the U.S. Food and Drug Administration (FDA) for its respiratory syncytial virus (RSV)…
Read MoreModerna signs agreement with China to advance mRNA medicines
CHINA —Moderna, the renowned vaccine developer, has made a significant stride by signing a transformative deal to produce mRNA medicines within China. This partnership comes in the wake of challenges…
Read MoreInnovative mRNA-based vaccine shows promise in combating deadly skin cancer
USA — Moderna and Merck & Co. have announced positive results of a midstage trial, revealing that the addition of an experimental mRNA-based vaccine reduced the risk of the most…
Read MoreModerna collaborates with IBM to integrate AI and Quantum Computing into development of mRNA therapies
USA — Moderna and IBM have announced a partnership aimed at utilizing generative artificial intelligence and quantum computing to further advance mRNA technology, which is the foundation of the company’s…
Read MoremRNA cancer vaccine shows promise in high-risk melanoma patients
USA— Moderna and Merck have collaborated on a personalized vaccine that can significantly reduce the risk of relapse in patients with melanoma, the most dangerous form of skin cancer. The…
Read More